Many experts have sounded the alarm that the COVID-19 pandemic is about shootingfirst and a larger agenda to impose authoritarian control around the world.2 Now, one shot has turned into two doses and a third booster shot. A fourth booster is also being discussed, including with Stéphane Bancel, CEO of Moderna, who said that the effectiveness of the third injection is likely to wear off within a few months, requiring another round soon. afterward.3
“I would be very surprised when we get that data in the coming weeks that it holds up well over time – I expect it to not be very good,” Bancel said in an interview with Goldman Sachs. Bancel said in an interview with Goldman Sachs.4 Conveniently, Moderna is working on an Omicron-specific jab that they hope to release as early as March 2022.5 – And this is just the beginning.
Writing on Substack, contributor Eugyppius explains, “Moderna, just one of many pharmaceuticals eager to tap into our new vaccine mania, are expanding their manufacturing capacity to produce up to 6 billion doses mRNA vaccine every year.”6 The information came straight from the mouth of a horse, at a virtual meeting held on the first day of the World Economic Forum’s (WEF) Davos 2022 Agenda, at a session titled “COVID-19: What is next?”7
Along with Bancel, the meeting was attended by Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID), Richard Hatchett, Executive Director of the Alliance for Innovation in Readiness. Epidemic Epidemic (CEPI), and professor Annelies Wilder-Smith from the London School of Hygiene and Tropical Medicine, who together detailed a blueprint for an indefinite “vaccine mania”.
Combined footage is planned to avoid ‘compliance issues’
During the discussion, Bancel said that Moderna is actively preparing for “a vaccine that should be available by the fall of 2022, and what it should contain.” The company is “working with public health experts like Fauci’s team to figure this out. Because we will soon have to decide which vaccines will be used in the fall of 2022,” he said.8
Fauci’s NIAID is part of the US National Institutes of Health (NIH), which some may be surprised to learn, actually owns half of the patents for Moderna’s COVID-19 injectable. In fact, the NIH owns thousands of pharmaceutical patents, and the US Centers for Disease Control and Prevention spends $4.9 billion of its $12 billion budget each year on vaccine purchases and distribution.
“Tony Fauci was able to select, appoint, four of his senior employees, who would each receive their own patent shares,” said Robert F. Kennedy Jr in an interview with James Corbett.9 “They will collect $150,000 a year for life if the Moderna vaccine is approved.”ten
In addition to working closely with Fauci, Moderna is planning to combine multiple injections, such as a COVID-19 shot, a flu shot, and a respiratory syncytial virus (RSV) shot, into one shot – which will be out. eyes in 2023 – to avoid “compliance issues.” He said:11
“The other part that we’re working on is for 2023, how do we go about doing that from the societal point of view that people want to be vaccinated?
And we’re going to do this by preparing combinations, we’re working on a flu vaccine, we’re working on an RSV vaccine, and our goal is to be able to have a daily booster shot. year, so that we don’t have compliance issues, where people don’t want to get two or three shots in the winter, but they do get a single dose, where they get aura boosters, and flu boosters and RSV, to make sure everyone gets vaccinated. ”
When asked how soon this will happen, he continued:twelfth,13
“So the RSV program is currently in Phase 3, the flu program is in Phase 2, and soon Phase 3, I hope as early as Q2 of this year. So the best case would be fall of 2023, as a best case I don’t think it will [be available] in every country, but we believe it could work in some countries next year. “
Vaccinations against at least 20 pathogens during operation
SARS-Cov-2 isn’t the only virus that Moderna and other drug companies, along with health officials, are intent on targeting with more shots. Remember the Zika virus, described by Kennedy as another pandemic created with the aim of selling pharmaceuticals and strengthening authoritarian control?14 There is a vaccine on the way.
What about Nipah virus? The Nipah virus, an animal-to-human pathogen with no known cure, was the inspiration for the movie “Contagion”.15 Viruses can only be tested in BSL-4 laboratories. Additionally, the National Biological and Agricultural Defense Facility in Kansas will be the first biocontrol facility16 in the United States, where it is possible to conduct research on Nipah (and Ebola) in livestock.
In 2019, Nipah Malaysia was also among the deadly virus strains transported17 from the National Microbiology Laboratory of Canada to the Wuhan Institute of Virology. If you haven’t heard of Nipah, you probably will soon – another vaccine is being used for it. Bancel says:18,19
“We are working with Dr. Fauci’s team, we are working with Richard [Hatchett]to fight more pathogens… The entire scientific community has known for many years that there are at least about 20 potential pathogens for which we need vaccines, you know, we have zika vaccines in Phase 2 … we’re working on a Nipah vaccine, which are viruses that not everyone has heard of.
Because we need data. What dose is needed, made up from a genetic standpoint… so that if a new pathogen emerges from that family, we can very quickly move to Stage 3.”
More mRNA footage coming soon
Various other vaccines are also in development, including a Phase 3 study looking at combining Pfizer’s COVID-19 injection with their Prevnar 20™ (20-valent pneumococcal conjugate vaccine) for adults 65 years and older.20
In a related news release, Kathrin U. Jansen, Ph.D., Senior Vice President and head of vaccine research and development at Pfizer spoke about the importance of “raising awareness.” awareness of the importance of immunization for adults,” recalling Bancel’s desire to create combination shots so that adults can get multiple vaccines at a single doctor or pharmacy visit.
“As the COVID-19 vaccine and booster dose continue to be used, we believe that healthcare providers have an opportunity to talk to their adult patients about different types of vaccines,” she said. other recommended vaccines according to CDC guidelines.”21
An agreement between Pfizer and BioNTech to develop the first mRNA vaccine was also reached in January 2022.22 According to a Pfizer news release, “Although there are currently approved vaccines for shingles, there is still an opportunity to develop an improved vaccine that is likely to show high efficacy and potential. better tolerated, and more efficient to produce globally, using mRNA technology.”23
A Moderna Phase 1 study of Epstein-Barr mRNA virus shot is also underway. The first dose of the trial was administered to a study subject on January 5, 2022,. In a press release, Moderna detailed their intentions to launch additional mRNA vaccines against several additional viruses:24
“The start of this Phase 1 study is an important milestone as we continue to improve mRNA vaccines against latent viruses, which persist in the body for life after infection and can Moderna is committed to developing a first-in-class vaccine against latent viruses for which there are currently no approved vaccines, including vaccines against again CMV [cytomegalovirus]EBV and HIV.
Our research team is working to bring even more vaccines against latent viruses to the clinic. We believe these vaccines can have a profound impact on the quality of life of hundreds of millions of people around the world. “
Other mRNA snapshots also in development include:
- mRNA cancer vaccine for non-small cell lung cancer (NSCLC)25
- influenza mRNA vaccination, which is being developed by several companies, including Pfizer, Moderna, Sanofi and Translate Bio26
- An HIV mRNA vaccine, one of which is being studied by Moderna in collaboration with the NIH27
- Multiple complementary mRNA cancer vaccines, including one targeting advanced melanoma – are being developed by BioNTech and Regeneron Pharmaceuticals28 – and several are being developed by Moderna, targeting melanoma, NSCLC, colorectal cancer and pancreatic cancer29
Increased production for billions of doses of medicine
In case there is any doubt that the major powers intend to use injections as an increasingly integral part of your healthcare routine and daily life, Bancel described the plan. produce billions of injections in a matter of months. He said during the WEF session:30,thirty first
“The rest is production. If you look at 2020, we were able to send 20 million doses to the US government when the vaccine was approved. That’s not much.
But this year we will have 2 to 3 billion doses of capacity in a 6 month time frame, which is what I believe we will have to get a vaccine permission, if all the work has been done before that. … you could have 1.5 billion doses available in six months, and that’s just from Moderna. And you have other backgrounds, it can be a much larger number…”
With censorship becoming more widespread and Big Tech colluding with dictators and pharmaceutical companies to bury the harms that come through these experimental vaccines – including death – now , it’s more important than ever to let your voice stand in favor of medical freedom and oppose health care by government officials who threaten, intimidate, and coerce citizens into violating their concentric beliefs.
The ethical principal of informed consent for medical risk-taking, including the legal right to make voluntary decisions about experimental injections, must be protected. For now, however, as Eugyppius explains:32
“The vaccination doctors are a great sword of Damocles over our heads. As I enter this, they are scouring the earth for the new pathogens their products claim, and they, along with their bureaucratic and academic allies, will do their best to be into vaccination campaigns and threaten new pandemics whenever possible – all Season flu, perhaps.”
